Trade

ANG Lifesciences India share price

High risk
  • 55%Low risk
  • 55%Moderate risk
  • 55%Balanced risk
  • 55%High risk
  • 55%Extreme risk
  • 23.26(-3.04%)
    March 5, 2026 15:25:21 PM IST
    • NSE
    • BSE
  • Vol : 1.12 K (NSE + BSE)
    Last 20 day avg : 3.66 K

ANG Lifesciences India is trading -3.04% lower at Rs 23.26 as compared to its last closing price. ANG Lifesciences India has been trading in the price range of 25.50 & 23.17. ANG Lifesciences India has given -18.82% in this year & 2.70% in the last 5 days. The company posted a net profit of -4.75 Crores in its last quarter.Listed peers of ANG Lifesciences India include Sun Pharmaceutical Industries (1.75%), Divi's Laboratories (0.99%), Torrent Pharmaceuticals (0.26%).The Mutual Fund holding in ANG Lifesciences India was at -% in . The MF holding has - from the last quarter. The FII holding in ANG Lifesciences India was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Mar 05, 2026, 02:37 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.40
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    1.30
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    0.48
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
23.17
Highest
25.50
52 week range
Lowest
21.03
Highest
39.70
ANG Lifesciences India Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bullish
1,780.001.754,27,071.5633.295.31.000.50
Divi's Laboratories
Neutral
6,362.000.991,69,123.3373.2210.730.500.01
Torrent Pharmaceuticals
Bullish
4,353.150.261,47,756.6369.5417.660.8117.62
Cipla
Bearish
1,325.600.991,07,091.6420.313.430.980.81
Dr Reddy's Laboratories
Bullish
1,307.001.231,09,082.7417.933.020.662.34
ANG Lifesciences India Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-14Quarterly Results
2025-11-14Quarterly Results
2025-08-14Quarterly Results
2025-05-30Audited Results
2025-02-14Quarterly Results
About the company ANG Lifesciences India
  • IndustryBiotechnology & Drugs
  • ISININE236W01016
  • BSE Code540694
  • NSE Code
ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and printing and packaging. The Company's product portfolio includes various products comprising therapeutic categories, such as Antibiotics, Antiviral, Antimalarial, Antiulcer, Carbapenem, Corticosteroid, Penicillin and Beta Lactamase Inhibitor. The Company’s product category includes Dry Powder Injection, Liquid Injections, Hard Gelatin Capsule, Tablet Beta Lactum, Tablets, Liquid Suspension /Syrup, Ointment/Creams, and Soft Gelatin Capsule. Its Dry Powder Injection products include Ampicillin & Cloxacillin for injection 500mg, Azetronam for Injection USP 500mg, Ampicillin Injection 1.0gm, Ceftriaxone Injection 250mg, Amoxycillin & Potassium Clavulanate for injection 1.2gm, and others.
  • Management Info
  • Harshita AggarwalCompliance Officer, Company Secretary
  • Rajesh GuptaManaging Director, Director
ANG Lifesciences India Share Price FAQs

ANG Lifesciences India is trading at 23.26 as on Thu Mar 05 2026 09:55:21. This is -3.04% lower as compared to its previous closing price of 23.99.

The market capitalization of ANG Lifesciences India is 30.38 Cr as on Thu Mar 05 2026 09:55:21.

The 52 wk high for ANG Lifesciences India is 39.70 whereas the 52 wk low is 21.03

ANG Lifesciences India can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: 21.23
  • Dividend Yield: 0.00%
  • D/E ratio: -

ANG Lifesciences India reported a net profit of -12.41 Cr in 2025.